TP53 and neoplasm: In fact, survival analysis of early gastric cancer or advanced gastric cancer in TCGA database show no significant clinical outcomes in overall survival (OS) based on TP53 status in tumor tissue, which is consistent with previous reports (Bellini et al., 2012).